You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Autonomous, Unattended, Reagentless Biological Agent Detector
SBC: Orono Spectral Solutions Inc. Topic: CBD05111The goal of this project is to investigate the feasability of a unique sampling method that will lead to the development of a reagentless infrared (IR) based BW agent detection system. The current JPBDS uses lateral flow immunoassay technology as the final step in detecting bioagents, and has a detection limit of 10^5 spores/ml[ref 1]. Preliminary data from our infrared approach indicates a mini ...
SBIR Phase I 2005 Department of DefenseOffice for Chemical and Biological Defense -
Handheld Photoacoustic Chemical Agent and Toxic Industrial Material Detector
SBC: MANNING APPLIED TECHNOLOGY Topic: CBD05112Manning Applied Technology proposes to develop a handheld infrared spectrometer, ideally suited to detection of airborne chemical agents at and below permissible exposure limits. This approach offers unmatched sensitivity and specificity for detection of all types of chemical vapors. The instrument is modular, rugged, compact and highly sensitive. Volume pricing will be less than $1000 each. ...
SBIR Phase I 2005 Department of DefenseOffice for Chemical and Biological Defense -
Nanodroplet PCR Lab-Chip for Clinical Pathogen Detection
SBC: ADVANCED LIQUID LOGIC Topic: N/ADESCRIPTION (provided by applicant): Rapid and accurate detection and identification of pathogens is crucial for the effective management and treatment of infectious disease. While molecular diagnostic techniques including PCR are a promising approach for rapid and sensitive detection of pathogens, they suffer from a number of technical drawbacks which have slowed their acceptance in the clinic. ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Discovery of Peptide-based Bone Morphogenic Protein Mimetics
SBC: AFFINERGY, LLC Topic: N/ADESCRIPTION (provided by applicant): In this proposal, we present a novel approach for the identification and immobilization of a BMP mimetic. We plan to use phage display technology to identify peptides that mimic BMP-like signaling of the BMP receptors. These peptides will be linked to a previously identified high-affinity, collagen-binding peptide. The resulting hybrid molecule will allow contr ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Improved Orthopedic Implant Surface Coatings
SBC: AFFINERGY, LLC Topic: N/AEndosseous metallic implants are common alloplastic devices used in medicine and dentistry. The orthopedic and dental marketplace continues to grow and indications for implants are expanding. There is a perceived need to improve both the successful healing (osseointegration) and the long term outcome of implants by control of interfacial reactivity during healing and remodeling. The growth of know ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Electrochemical RT activity assay for measuring HIV load
SBC: ALDERON BIOSCIENCES, INC. Topic: N/ADESCRIPTION (provided by applicant): In this Phase I SBIR project Alderon Biosciences Inc. (ABI) proposes to demonstrate the feasibility of using electrochemical reverse transcriptase (eRT) assays for determinations of HIV viral load in clinical samples. Success will set the stage for Phase II development, FDA approval, and production of commercial kits using this advanced technology. The long-r ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Electrochemical Quantification of HCV RNA
SBC: ALDERON BIOSCIENCES, INC. Topic: N/ADESCRIPTION (provided by applicant): The National Institutes of Allergy and Infectious Disease have called for better tools for the detection and diagnosis of emerging and re-emerging infectious diseases. To meet this need, Alderon Biosciences Inc. (ABI) proposes to develop innovative, low-cost tests with sensitivity adequate for determining HCV viral load. Reliable and affordable HCV viral load t ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
CARRAGEENAN-STABILIZED COLLOIDAL GOLD BIOSENSOR ELECTRODES
SBC: ALDERON BIOSCIENCES, INC. Topic: N/AN/A
SBIR Phase I 1987 Department of Health and Human Services -
rAAV Revitalized Structural Allografts
SBC: ASKLEPIOS BIOPHARMACEUTICAL, INC. Topic: N/ADESCRIPTION (provided by applicant): Repair of large structural bone defects remains a major problem in orthopaedic reconstruction surgery due to the limited supply of cortical bone autograft and the poor long-term outcomes obtained with structural allografts. While there is no substitute for structural allografts, based on their biomechanical and biocompatible properties, their lack of osteogenic ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
ENZYME-LINKED IMMUNOSORBENT ASSAY FOR COTININE
SBC: Binax Inc Topic: N/ATHE LONG-TERM OBJECTIVE OF THE PROPOSED WORK IS TO PROVIDE PHYSICIANS AND OTHERS IN THE FIELD OF PREVENTIVE HEALTH CARE DELIVERY WITH AN INEXPENSIVE AND RELIABLE BIOCHEMICAL TEST TO MEASURE PATIENTS' EXPOSURE TO TOBACCO SMOKE. AT PRESENT, A RELIABLE TEST OF THIS TYPE IS NOT AVAILABLE ON A COMMERCIAL BASIS. COTININE, A METABOLITE OF NICOTINE, HAS BEEN SELECTED AS THE PRODUCT TO MEASURE BECAUSE OF I ...
SBIR Phase I 1987 Department of Health and Human Services